393 a Trial to Determine the Effect of Psoriasis Treatment (Adalimumab, Phototherapy, and Placebo) on Cardiometabolic Disease: The Vascular Inflammation in Psoriasis (VIP) Trial

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2018.03.400
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

538 the Vascular Inflammation in Psoriasis (VIP) Trial: A Secondary Analysis of Patient Reported Outcomes for Patients Treated With Adalimumab, Phototherapy, or Placebo

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

A Phase IV, Randomized, Double-Blind, Placebo-Controlled Crossover Study of the Effects of Ustekinumab on Vascular Inflammation in Psoriasis (The VIP-U Trial)

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2020English

Adalimumab for the Treatment of Psoriasis

Health Technology Assessment
MedicineHealth Policy
2009English

Adalimumab for Nail Psoriasis: Efficacy and Safety From the Open-Label Extension of a Phase-3, Randomized, Placebo-Controlled Trial

SKIN The Journal of Cutaneous Medicine
2017English

Adalimumab for Nail Psoriasis: Efficacy and Safety From the First 26 weeks of a Phase 3, Randomized, Placebo-Controlled Trial

Journal of the American Academy of Dermatology
Dermatology
2018English

Adalimumab for Nail Psoriasis: Efficacy and Safety Over 52 Weeks From a Phase‐3, Randomized, Placebo‐Controlled Trial

Journal of the European Academy of Dermatology and Venereology
DermatologyInfectious Diseases
2019English

Phototherapy of Psoriasis

Bőrgyógyászati és Venerológiai Szemle
2018English

The Patient’s Guide to Psoriasis Treatment. Part 2: PUVA Phototherapy

Dermatology and Therapy
Dermatology
2016English

Oral Curcumin in the Treatment of Moderate to Severe Psoriasis Vulgaris: A Prospective Clinical Trial

Journal of the American Academy of Dermatology
Dermatology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy